期刊文献+

mTOR信号通路在造血及其它系统衰老中作用的研究进展 被引量:4

Recent Advances of Studies on Role of mTOR Signaling in Aging of Hematopoietic and Other Organ Systems——Review
下载PDF
导出
摘要 哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)是一种丝/苏氨酸蛋白激酶,在调节细胞的生长、增殖和存活中起着重要的作用。mTOR复合体调控mRNA的转录、核糖体的合成及代谢相关基因的表达,通过磷酸化其下游的靶蛋白如S6蛋白激酶和4E-BP1等来调节细胞的活动。近年来,mTOR分子及其相关信号通路在衰老调控中所起的作用渐渐被人们所认识。对mTOR信号通路在衰老中的生物学功能和调节机制的研究,不仅可以深入了解细胞自我更新和分化的机制,而且对衰老及其相关疾病的治疗、预防及寻找潜在的治疗靶点与药物具有重要意义。本文主要介绍mTOR信号通路在造血系统及其他系统衰老中研究的最新进展。 Mammalian target of rapamycin(mTOR) is a serine/threonine protein kinase, which plays an essential role in cell growth, proliferation and survival, mTOR regulates the transcription of mRNA, synthesis of ribosome and gene expression for metabolism. By forming mTOR complex, it regulates cellular activities by phosphorylating its downstream proteins, such as S6 protein kinase and 4E-BP1. In recent years, the role of mTORC1 in regulating aging is gradually recognized. Studies of physiological function and the regulatory mechanisms of mTOR signaling can not only help to better understand the aging mechanism for ceils or organs, but also provide insights as to finding potential new drug targets for aging related diseases. This review focuses on recent advances of roTOR and aging related diseases in hematopoietic and other organ systems.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2013年第5期1313-1317,共5页 Journal of Experimental Hematology
基金 科技部973项目(编号2012CB966604,2010CB945204) 科技部重大国际合作项目(编号2010DFB30270) 国家重大医药专项项目(编号2011ZX09102-010-04) 国家自然科学基金项目(编号81090410,81130074,30825017)
关键词 MTOR信号通路 造血系统 衰老 mTOR signaling hematopoietic system aging
  • 相关文献

参考文献41

  • 1Verdaguer E,Junyent F,Folch J,et al.Aging biology:a new frontier for drug discovery.Expert Opin Drug Discov,2012;7 (3):217-229. 被引量:1
  • 2王伟丽,张英弛,曾慧敏,华春兰,魏蔚,许静,竺晓凡,程涛,袁卫平.PI3K/AKT信号通路在急性白血病中调控机制的初步研究[J].中国实验血液学杂志,2012,20(1):18-21. 被引量:10
  • 3Fingar DC,Blenis J.Target of rapamycin (TOR):an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression.Oncogene,2004 ;23 (18):3151-3171. 被引量:1
  • 4Tokunaga C,Yoshino K,Yonezawa K.mTOR integrates amino acid-and energy-sensing pathways.Biochem Biophys Res Commun,2004;313(2):443-446. 被引量:1
  • 5Populo H,Lopes JM,Soares P.The mTOR signalling pathway in human cancer.Int J Mol Sci,2012; 13(2):1886-1918. 被引量:1
  • 6De Virgilio C,Loewith R.The TOR signalling network from yeast to man.Int J Biochem Cell biol,2006 ;38 (9):1476-1481. 被引量:1
  • 7Polak P,Hall MN.mTOR and the control of whole body metabolism.Curr Opin Cell Biol,2009 ;21 (2):209-218. 被引量:1
  • 8Zhao L,Vogt PK.Hot-spot mutations in p110alpha of phosphatidylinositol 3-kinase (pI3K):differential interactions with the regulatory subunit p85 and with RAS.Cell Cycle,2010;9 (3):596-600. 被引量:1
  • 9Franke TF,Kaplan DR,Cantley LC,et al.Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate.Science,1997 ;275 (5300):665-668. 被引量:1
  • 10Liu M,Wilk SA,Wang A,et al.Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR.J Biol Chem,2010;285(47):36387-36394. 被引量:1

二级参考文献12

  • 1Osaki M,Oshimura M,Ito H,et al.PI3K/AKT pathway:its func-tions and alterations in human cancer.Apoptosis,2004;9(6):667-676. 被引量:1
  • 2Livak KJ,Schmittgen TD.Analysis of relative gene expression datausing real-time quantitative PCR and the 2(-Delta Delta C(T))Method.Methods,2001;25(4):402-408. 被引量:1
  • 3Karoui M,Tresallet C,Julie C,et al.Loss of heterozygosity on 10qand mutational status of PTEN and BMPR1A in colorectal primarytumours and metastases.Br J Cancer,2004;90(6):1230-1234. 被引量:1
  • 4Nassif NT,Lobo GP,Wu X,et al.PTEN mutations are common insporadic microsatellite stable colorectal cancer.Oncogene,2004;23(2):617-628. 被引量:1
  • 5Colakoglu T,Yildirim S,Kayaseleuk F,et al.Clinicopathologicalsignificance of PTEN loss and the phosphoinositide 3-kinase/Aktpathway in sporadic colorectal neoplasms:is PTEN loss predictor oflocal recurrence?Am J Surg,2008;195(6):719-725. 被引量:1
  • 6Manning BD,Cantley LC.AKT/PKB signaling:navigating down-stream.Cell,2007;129(7):1261-1274. 被引量:1
  • 7Cheng GZ,Park S,Shu S,et al.Advances of AKT pathway in hu-man oncogenesis and as a target for anti-cancer drug discovery.CurrCancer Drug Targets,2008;8(1):2-6. 被引量:1
  • 8Sabatini DM.mTOR and cancer:insights into a complex relation-ship.Nat Rev Cancer,2006;6(9):729-734. 被引量:1
  • 9Campbell RA,Bhat-Nakshatri P,Patel NM,et al.Phosphatidylinos-itol 3-kinase/AKT-mediated activation of estrogen receptor alpha:anew model for anti-estrogen resistance.J Biol Chem,2001;276(13):9817-9824. 被引量:1
  • 10Brunet A,Bonni A,Zigmond MJ,et al.Akt promotes cell survivalby phosphorylating and inhibiting a Forkhead transcription factor.Cell,1999;96(6):857-868. 被引量:1

共引文献9

同被引文献74

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部